# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this...
On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement...
Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchan...